Health AI in the 2nd Week of May

Ludi (US): Launched Ludi Boost, an AI-enabled provider compensation and workforce management offering combining technology, operations, and governance support. [Link]

Freed (US): Launched an AI coding assistant that generates ICD-10 and CPT codes directly from patient encounters, helping clinicians improve documentation accuracy and reduce billing denials. [Link]

Weave Bio (US): Expanded its AI-native platform to support New Drug Applications in partnership with Parexel, reducing submission authoring timelines by over 60% through automated data synthesis and document generation. [Link]

WellSky (US): Launched AI-powered ambient documentation for personal care agencies, reducing care plan documentation time from up to three hours to around one hour per client. [Link]

Hippocratic AI (US): Released Polaris 5.0, a healthcare-specific voice AI trained on 180 million patient interactions. The model introduces real-time clinical escalation, acoustic biomarker detection, and multi-document reasoning, with benchmark gains in safety and drug-related tasks. [Link]

ZERO Prostate Cancer (US): Launched ZACH, an SMS-based AI support tool offering 24/7 prostate cancer information, guidance, and support without requiring a smartphone app. [Link]

Medline (US): Launched Mpower, an AI-powered supply chain control tower for healthcare providers, with early users reporting more than 50% efficiency gains in order substitution workflows. [Link]

Sutter Health (US): Faced a class-action lawsuit alleging ambient AI tools recorded and transmitted patient conversations without proper consent, raising legal questions around privacy and AI use in clinical settings. [Link]

Infor (US): Released UK research showing data security, talent gaps, and infrastructure remain major barriers to scaling enterprise AI, including in regulated sectors such as healthcare. [Link]

BDO (US): Published guidance arguing that healthcare AI governance should include clear ownership, data quality checks, transparency, bias monitoring, and ongoing performance review. [Link]

KFF (US): Released a policy brief warning that AI in healthcare could worsen racial and ethnic disparities if models are trained on biased or non-representative data. [Link]

American Journal of Bioethics (Global): Published a commentary proposing an “AI Ethics 2.0” framework for governing agentic AI in healthcare through continuous monitoring and stronger oversight. [Link]

El Salvador Government (El Salvador): Rolled out a national program using Google Gemini to monitor chronic diseases via the DoctorSV app, combining AI screening, lab testing, and specialist follow-up. The deployment has raised concerns around cost and data security. [Link]

Kenya Government (Kenya): Faced backlash over an AI-based system used to estimate household income for public health insurance, with investigations finding it overcharged lower-income citizens. [Link]

Google DeepMind (UK): Announced its “AI co-clinician” research initiative, exploring multimodal AI to support clinicians, with simulations showing strong performance but limitations in identifying critical clinical signals. [Link]

Harvard Medical School (US): Published a Science study showing an LLM matched or exceeded physicians on clinical reasoning tasks using published cases and real emergency department records. [Link]

FDA (US): Launched a real-time clinical trials pilot with AstraZeneca, Amgen, and Paradigm Health to report key safety and efficacy signals to regulators in near real time. [Link]

Profluent (US): Partnered with Eli Lilly in a deal worth up to $2.25B to use AI models to design site-specific recombinases for genetic medicine. [Link]

Circular Genomics (US): Partnered with Vitazi.ai to develop a multimodal Alzheimer’s detection workflow combining AI-powered retinal imaging with blood-based circular RNA biomarkers. [Link]

Viz.ai (US): Partnered with the National Rural Health Association to help rural health systems understand and implement AI through education, case studies, and practical guidance. [Link]

American Urological Association (US): Collaborated with OpenEvidence to make AUA clinical practice guidelines accessible within its AI-powered clinical decision support platform. [Link]

KAI Conversations (UK): Partnered with Syneos Health to bring AI-powered conversation intelligence into U.S. biopharma field teams, turning HCP interactions into commercial insights. [Link]

UberDoc (US): Partnered with XY.AI Labs to give its network of 5,000+ specialists access to AI agents for scheduling, insurance verification, prior authorization, coding, and billing support. [Link]

Jharkhand Government (India): Approved AI adoption in healthcare and a collaboration with Google to strengthen digital health infrastructure, diagnostics, data management, and access in underserved areas. [Link]

Anthropic (US): Partnered with Blackstone, Hellman & Friedman, and Goldman Sachs to launch an enterprise AI services firm that will deploy Claude across workflows in sectors including healthcare. [Link]

Iterative Health (US): Raised $77M in Series C funding to expand its AI-enabled multispecialty clinical research network and accelerate trial execution. [Link]

Axoft (US): Raised $55M to advance clinical trials and pursue FDA clearance for its ultra-soft brain-computer interface for coma patients with covert consciousness. [Link]

Techcyte (US): Raised $15M to expand its AI-powered digital pathology platform and support growth across human, veterinary, and environmental diagnostics. [Link]

SquareMind (France): Raised $18M to scale its AI-powered robotic skin-scanning platform, Swan, for automated full-body dermoscopy and early skin cancer detection. [Link]

Dehaze (Germany): Raised €3.2M in seed funding to expand its AI platform for early chronic disease detection using heterogeneous patient data. [Link]

Aidoc (Israel): Raised $150M in Series E funding led by Goldman Sachs to expand its CARE clinical foundation model and enterprise AI platform for diagnostic imaging workflows. [Link]

Medisolv (US): Acquired Health Elements AI to automate clinical data abstraction for quality reporting and registry workflows. [Link]

Parexel (US): Acquired Vitrana to expand its AI-powered pharmacovigilance capabilities, enabling automated monitoring of drug safety across the product lifecycle. [Link]

Carlyle (US): Acquired majority stakes in Knack RCM and EqualizeRCM to create an AI-native, global healthcare revenue cycle management platform. [Link]

Mobile-health Network Solutions (Singapore): Signed a non-binding US$119M framework with Hector Capital to support proposed majority acquisitions of BIMA and M&M Helix, expanding its AI-powered healthcare footprint across Asia and Africa. [Link]